Technical Analysis for NAVB - Navidea Biopharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 0.04 0.00% 0.00
NAVB closed unchanged on Monday, March 18, 2024, on 19 percent of normal volume. It ran into resistance at its 50 day moving average.
Earnings due: Mar 19
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
50 DMA Resistance Bearish 0.00%
Fell Below 20 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%

   Recent Intraday Alerts

Alert Time
20 DMA Support about 18 hours ago
10 DMA Support about 18 hours ago
50 DMA Support about 18 hours ago
Gap Up Closed about 18 hours ago
60 Minute Opening Range Breakdown about 18 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Navidea Biopharmaceuticals, Inc. Description

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. The company's radiopharmaceutical development programs include Lymphoseek Injection, a receptor-targeted small-molecule investigational radiopharmaceutical that is used in lymphatic mapping procedures, which are performed to help stage breast cancer and melanoma; and NAV4694, an F-18 radiolabeled positron emission tomography imaging agent, which is used as an aid in the diagnosis of patients with signs or symptoms of cognitive impairment, such as Alzheimer's disease. Its radiopharmaceutical development programs also comprise NAV5001, an Iodine-123 radiolabeled single photon emission computed tomography imaging agent that is used as an aid in the diagnosis of Parkinson's disease and other movement disorders with potential use as a diagnostic aid in dementia; and RIGScan, a radiolabeled monoclonal antibody that is developed as a diagnostic aid for use during surgery to help surgeons locate occult or metastatic cancer, primarily colorectal cancer. It has research and development agreements with University of California, AstraZeneca AB, Alseres Pharmaceuticals, Inc., and The Ohio State University. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012. Navidea Biopharmaceuticals, Inc. was founded in 1983 and is headquartered in Dublin, Ohio.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Surgery Monoclonal Antibody Alzheimer's Disease Breast Cancer Parkinson's Disease Melanoma Colorectal Cancer Dementia Medical Physics Movement Disorders Radiopharmaceuticals Tomography Imaging Agent Nuclear Medicine Cognitive Impairment Metastasis Iodine Positron Emission Tomography Medicinal Radiochemistry Metastatic Cancer

Is NAVB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.34
52 Week Low 0.021
Average Volume 127,345
200-Day Moving Average 0.07
50-Day Moving Average 0.05
20-Day Moving Average 0.04
10-Day Moving Average 0.04
Average True Range 0.01
RSI (14) 43.50
ADX 14.81
+DI 18.27
-DI 10.02
Chandelier Exit (Long, 3 ATRs) 0.03
Chandelier Exit (Short, 3 ATRs) 0.06
Upper Bollinger Bands 0.05
Lower Bollinger Band 0.03
Percent B (%b) 0.32
BandWidth 43.67
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0003
Fundamentals Value
Market Cap 3.71 Million
Num Shares 100 Million
EPS -0.20
Price-to-Earnings (P/E) Ratio -0.19
Price-to-Sales 6110.08
Price-to-Book 8.16
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.06
Resistance 3 (R3) 0.06 0.05 0.05
Resistance 2 (R2) 0.05 0.05 0.05 0.05
Resistance 1 (R1) 0.05 0.05 0.04 0.04 0.05
Pivot Point 0.04 0.04 0.04 0.04 0.04
Support 1 (S1) 0.03 0.04 0.03 0.03 0.02
Support 2 (S2) 0.03 0.03 0.03 0.02
Support 3 (S3) 0.02 0.03 0.02
Support 4 (S4) 0.02